CWM
CarsonAllaria Wealth Management’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.8K | Hold |
71
| – | – | 0.01% | 248 |
|
2025
Q1 | $10.7K | Hold |
71
| – | – | 0.01% | 247 |
|
2024
Q4 | $13.1K | Hold |
71
| – | – | 0.01% | 228 |
|
2024
Q3 | $14K | Hold |
71
| – | – | 0.01% | 233 |
|
2024
Q2 | $14.7K | Hold |
71
| – | – | 0.01% | 219 |
|
2024
Q1 | $19.2K | Hold |
71
| – | – | 0.01% | 192 |
|
2023
Q4 | $16.8K | Hold |
71
| – | – | 0.01% | 184 |
|
2023
Q3 | $13.9K | Hold |
71
| – | – | 0.01% | 185 |
|
2023
Q2 | $14.9K | Hold |
71
| – | – | 0.01% | 191 |
|
2023
Q1 | $14.3K | Hold |
71
| – | – | 0.01% | 187 |
|
2022
Q4 | $15K | Hold |
71
| – | – | 0.01% | 167 |
|
2022
Q3 | $14K | Hold |
71
| – | – | 0.01% | 167 |
|
2022
Q2 | $15K | Hold |
71
| – | – | 0.01% | 160 |
|
2022
Q1 | $20K | Hold |
71
| – | – | 0.02% | 162 |
|
2021
Q4 | $27K | Buy |
+71
| New | +$27K | 0.02% | 157 |
|